Phenylalanine stimulates the release of glucagon-like peptide-1 (GLP-1) and peptide tyrosine–tyrosine (PYY), decreases plasma ghrelin, stimulates the release of insulin, improves glucose tolerance in rats, and affects the development of diabetes (Alamshah et al., 2017). Here, INS is linked to diabetes mellitus.